
March 23, 2011 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science
March 23, 2011 Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

March 22, 2011 Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib
March 21, 2011 Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

March 18, 2011 Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

March 18, 2011 Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing
March 17, 2011 Research and Development BIA, R&D tax credits, biotech

March 17, 2011 Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

March 16, 2011 Research and Development Horsham, Novartis, respiratory

March 16, 2011 Research and Development Horsham, Novartis, job cuts, pharma job cuts
March 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

March 15, 2011 Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts
March 14, 2011 Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology
March 14, 2011 Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes
March 14, 2011 Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development